Page last updated: 2024-08-24

arsenic trisulfide and cyclosporine

arsenic trisulfide has been researched along with cyclosporine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, S; Ding, W; Pan, M; Tong, Y; Zhang, X	1

Other Studies

1 other study(ies) available for arsenic trisulfide and cyclosporine

Article	Year
Study of Arsenic Sulfide in Solid Tumor Cells Reveals Regulation of Nuclear Factors of Activated T-cells by PML and p53. Scientific reports, 2016, Jan-22, Volume: 6 Topics: Arsenicals; Cell Death; Cell Proliferation; Cell Survival; Colonic Neoplasms; Cyclosporine; Down-Regulation; Drug Synergism; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; HCT116 Cells; Humans; Models, Biological; NFATC Transcription Factors; Promoter Regions, Genetic; Promyelocytic Leukemia Protein; Proto-Oncogene Proteins c-myc; RNA, Messenger; Sulfides; Transcription, Genetic; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays	2016

Article

Year

Study of Arsenic Sulfide in Solid Tumor Cells Reveals Regulation of Nuclear Factors of Activated T-cells by PML and p53.

Scientific reports, 2016, Jan-22, Volume: 6

Topics: Arsenicals; Cell Death; Cell Proliferation; Cell Survival; Colonic Neoplasms; Cyclosporine; Down-Regulation; Drug Synergism; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; HCT116 Cells; Humans; Models, Biological; NFATC Transcription Factors; Promoter Regions, Genetic; Promyelocytic Leukemia Protein; Proto-Oncogene Proteins c-myc; RNA, Messenger; Sulfides; Transcription, Genetic; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2016